| mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
0.0046 |
0.9 |